Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Tyrosine Kinase Inhibitor Therapy in Locally Advanced Differentiated Thyroid Cancer: A Case Report.

Stewart KE, Strachan MWJ, Srinivasan D, MacNeill M, Wall L, Nixon IJ.

Eur Thyroid J. 2019 Apr;8(2):102-107. doi: 10.1159/000494880. Epub 2019 Jan 17.

PMID:
31192150
2.

Hypertrabeculation as a Noncompaction Phenotype in Dilated Cardiomyopathy Defined by Contrast Echocardiography.

Nishimura M, Igata S, Wong DJ, Wettersten N, Kahn AM, Raisinghani A, Blanchard DG, Strachan M, DeMaria AN.

JACC Cardiovasc Imaging. 2019 Mar 8. pii: S1936-878X(19)30150-0. doi: 10.1016/j.jcmg.2019.01.020. [Epub ahead of print] No abstract available.

PMID:
30878434
3.

Predictive Factors for Progression of Mitral Regurgitation in Asymptomatic Patients With Mitral Valve Prolapse.

Ma JI, Igata S, Strachan M, Nishimura M, Wong DJ, Raisinghani A, DeMaria AN.

Am J Cardiol. 2019 Apr 15;123(8):1309-1313. doi: 10.1016/j.amjcard.2019.01.026. Epub 2019 Jan 24.

PMID:
30711245
4.

Illumination pattern design with deep learning for single-shot Fourier ptychographic microscopy.

Cheng YF, Strachan M, Weiss Z, Deb M, Carone D, Ganapati V.

Opt Express. 2019 Jan 21;27(2):644-656. doi: 10.1364/OE.27.000644.

PMID:
30696147
5.

Predicting outcomes and complications following radioiodine therapy in Graves' thyrotoxicosis.

Aung ET, Zammitt NN, Dover AR, Strachan MWJ, Seckl JR, Gibb FW.

Clin Endocrinol (Oxf). 2019 Jan;90(1):192-199. doi: 10.1111/cen.13873. Epub 2018 Oct 25.

PMID:
30291728
6.

Diurnal profile of interstitial glucose following dexamethasone prophylaxis for chemotherapy treatment of gynaecological cancer.

Lyall MJ, Thethy I, Steven L, MacKean M, Nussey F, Sakala M, Rye T, Strachan MWJ, Dover AR.

Diabet Med. 2018 Nov;35(11):1508-1514. doi: 10.1111/dme.13770. Epub 2018 Aug 3.

PMID:
29938852
7.

Decreased iron stores are associated with cardiovascular disease in patients with type 2 diabetes both cross-sectionally and longitudinally.

Suárez-Ortegón MF, McLachlan S, Price AH, Fernández-Balsells M, Franch-Nadal J, Mata-Cases M, Barrot-de la Puente J, Mundet-Tudurí X, Mauricio D, Ricart W, Wild SH, Strachan MWJ, Price JF, Fernández-Real JM.

Atherosclerosis. 2018 May;272:193-199. doi: 10.1016/j.atherosclerosis.2018.03.028. Epub 2018 Mar 21.

PMID:
29625295
8.

Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial.

Reynolds RM, Denison FC, Juszczak E, Bell JL, Penneycard J, Strachan MWJ, Lindsay RS, Alexander CI, Love CDB, Whyte S, Mackenzie F, Stenson B, Norman JE.

BMC Pregnancy Childbirth. 2017 Sep 22;17(1):316. doi: 10.1186/s12884-017-1505-3.

9.

Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study.

Price AH, Weir CJ, Welsh P, McLachlan S, Strachan MWJ, Sattar N, Price JF.

Atherosclerosis. 2017 Sep;264:67-73. doi: 10.1016/j.atherosclerosis.2017.07.009. Epub 2017 Jul 12.

10.

Reply to Howlett and Mortimer

Strachan M W.

J R Coll Physicians Edinb. 2016 Dec;46(4):302. doi: 10.4997/JRCPE.2016.418. No abstract available.

PMID:
28690002
11.

Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes.

Jenks SJ, Conway BR, McLachlan S, Teoh WL, Williamson RM, Webb DJ, Welsh P, Sattar N, Strachan MWJ, Price JF.

Diabetologia. 2017 Aug;60(8):1400-1408. doi: 10.1007/s00125-017-4297-0. Epub 2017 May 20.

12.

The Prevalence of Lipoprotein(a) Measurement and Degree of Elevation Among 2710 Patients With Calcific Aortic Valve Stenosis in an Academic Echocardiography Laboratory Setting.

Wilkinson MJ, Ma GS, Yeang C, Ang L, Strachan M, DeMaria AN, Tsimikas S, Cotter B.

Angiology. 2017 Oct;68(9):795-798. doi: 10.1177/0003319716688415. Epub 2017 Jan 10.

PMID:
28068801
13.

Fatal haemorrhage following fine needle aspiration of the thyroid.

Strachan MW, Dalvi M, Ainsworth R, Gibb FW, Horsfall H, Patel D.

J R Coll Physicians Edinb. 2016 Sep;46(3):166-167. doi: 10.4997/JRCPE.2016.306.

PMID:
27959351
14.

BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.

Greenhalgh KA, Strachan MW, Alzahrani S, Baxter PD, Standeven KF, Storey RF, Ariens RA, Grant PJ, Price JF, Ajjan RA.

Thromb Haemost. 2017 Jan 26;117(2):295-302. doi: 10.1160/TH16-07-0554. Epub 2016 Dec 8.

15.

Thyrotropin Receptor Antibody Levels at Diagnosis and After Thionamide Course Predict Graves' Disease Relapse.

Tun NN, Beckett G, Zammitt NN, Strachan MW, Seckl JR, Gibb FW.

Thyroid. 2016 Aug;26(8):1004-9. doi: 10.1089/thy.2016.0017. Epub 2016 Jul 6.

PMID:
27266892
16.

Adrenal insufficiency in patients on long-term opioid analgesia.

Gibb FW, Stewart A, Walker BR, Strachan MW.

Clin Endocrinol (Oxf). 2016 Dec;85(6):831-835. doi: 10.1111/cen.13125. Epub 2016 Jun 28.

17.

Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.

Betz BB, Jenks SJ, Cronshaw AD, Lamont DJ, Cairns C, Manning JR, Goddard J, Webb DJ, Mullins JJ, Hughes J, McLachlan S, Strachan MWJ, Price JF, Conway BR.

Kidney Int. 2016 May;89(5):1125-1135. doi: 10.1016/j.kint.2016.01.015. Epub 2016 Mar 7.

PMID:
27083286
18.

Coronary artery spasm secondary to carcinoid syndrome.

Fenning SJ, Newby DE, Toumpanakis C, Strachan MW.

QJM. 2016 Jul;109(7):483-4. doi: 10.1093/qjmed/hcw050. Epub 2016 Mar 25. No abstract available.

PMID:
27016533
19.

Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis.

White J, Sofat R, Hemani G, Shah T, Engmann J, Dale C, Shah S, Kruger FA, Giambartolomei C, Swerdlow DI, Palmer T, McLachlan S, Langenberg C, Zabaneh D, Lovering R, Cavadino A, Jefferis B, Finan C, Wong A, Amuzu A, Ong K, Gaunt TR, Warren H, Davies TL, Drenos F, Cooper J, Ebrahim S, Lawlor DA, Talmud PJ, Humphries SE, Power C, Hypponen E, Richards M, Hardy R, Kuh D, Wareham N, Ben-Shlomo Y, Day IN, Whincup P, Morris R, Strachan MW, Price J, Kumari M, Kivimaki M, Plagnol V, Whittaker JC; International Consortium for Blood Pressure (ICBP), Smith GD, Dudbridge F, Casas JP, Holmes MV, Hingorani AD; UCLEB (University College London-London School of Hygiene & Tropical Medicine-Edinburgh-Bristol Consortium.

Lancet Diabetes Endocrinol. 2016 Apr;4(4):327-36. doi: 10.1016/S2213-8587(15)00386-1. Epub 2016 Jan 16.

20.

The prevalence of structural pituitary abnormalities by MRI scanning in men presenting with isolated hypogonadotrophic hypogonadism.

Dalvi M, Walker BR, Strachan MW, Zammitt NN, Gibb FW.

Clin Endocrinol (Oxf). 2016 Jun;84(6):858-61. doi: 10.1111/cen.13015. Epub 2016 Feb 12.

PMID:
26733239
21.

Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

Morling JR, Fallowfield JA, Guha IN, Williamson RM, Ali M, Glancy S, Strachan MW, Price JF.

QJM. 2016 Apr;109(4):249-56. doi: 10.1093/qjmed/hcv191. Epub 2015 Oct 9.

22.

The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors.

Feinkohl I, Price JF, Strachan MW, Frier BM.

Alzheimers Res Ther. 2015 Jun 10;7(1):46. doi: 10.1186/s13195-015-0130-5. eCollection 2015.

23.
24.

Adult height, coronary heart disease and stroke: a multi-locus Mendelian randomization meta-analysis.

Nüesch E, Dale C, Palmer TM, White J, Keating BJ, van Iperen EP, Goel A, Padmanabhan S, Asselbergs FW; EPIC-Netherland Investigators, Verschuren WM, Wijmenga C, Van der Schouw YT, Onland-Moret NC, Lange LA, Hovingh GK, Sivapalaratnam S, Morris RW, Whincup PH, Wannamethe GS, Gaunt TR, Ebrahim S, Steel L, Nair N, Reiner AP, Kooperberg C, Wilson JF, Bolton JL, McLachlan S, Price JF, Strachan MW, Robertson CM, Kleber ME, Delgado G, März W, Melander O, Dominiczak AF, Farrall M, Watkins H, Leusink M, Maitland-van der Zee AH, de Groot MC, Dudbridge F, Hingorani A, Ben-Shlomo Y, Lawlor DA; UCLEB Investigators, Amuzu A, Caufield M, Cavadino A, Cooper J, Davies TL; IN Day, Drenos F, Engmann J, Finan C, Giambartolomei C, Hardy R, Humphries SE, Hypponen E, Kivimaki M, Kuh D, Kumari M, Ong K, Plagnol V, Power C, Richards M, Shah S, Shah T, Sofat R, Talmud PJ, Wareham N, Warren H, Whittaker JC, Wong A, Zabaneh D, Davey Smith G, Wells JC, Leon DA, Holmes MV, Casas JP.

Int J Epidemiol. 2016 Dec 1;45(6):1927-1937. doi: 10.1093/ije/dyv074.

25.

Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes.

Feinkohl I, Keller M, Robertson CM, Morling JR, McLachlan S, Frier BM, Deary IJ, Strachan MW, Price JF.

Diabetologia. 2015 Jul;58(7):1637-45. doi: 10.1007/s00125-015-3581-0. Epub 2015 Apr 7.

26.

γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study.

Morling JR, Fallowfield JA, Williamson RM, Robertson CM, Glancy S, Guha IN, Strachan MW, Price JF.

Diabetologia. 2015 Jul;58(7):1484-93. doi: 10.1007/s00125-015-3575-y. Epub 2015 Mar 29.

27.

Oscillating Square Wave Transcranial Direct Current Stimulation (tDCS) Delivered During Slow Wave Sleep Does Not Improve Declarative Memory More Than Sham: A Randomized Sham Controlled Crossover Study.

Sahlem GL, Badran BW, Halford JJ, Williams NR, Korte JE, Leslie K, Strachan M, Breedlove JL, Runion J, Bachman DL, Uhde TW, Borckardt JJ, George MS.

Brain Stimul. 2015 May-Jun;8(3):528-34. doi: 10.1016/j.brs.2015.01.414. Epub 2015 Feb 16.

28.

The Role of Stress Exposure and Family Functioning in Internalizing Outcomes of Urban Families.

Sheidow AJ, Henry DB, Tolan PH, Strachan MK.

J Child Fam Stud. 2014 Nov;23(8):1351-1365.

29.

Prolonged Exposure for Guilt and Shame in a Veteran of Operation Iraqi Freedom.

Paul LA, Gros DF, Strachan M, Worsham G, Foa EB, Acierno R.

Am J Psychother. 2014 Sep 1;68(3):277-286.

30.

Sixty-five common genetic variants and prediction of type 2 diabetes.

Talmud PJ, Cooper JA, Morris RW, Dudbridge F, Shah T, Engmann J, Dale C, White J, McLachlan S, Zabaneh D, Wong A, Ong KK, Gaunt T, Holmes MV, Lawlor DA, Richards M, Hardy R, Kuh D, Wareham N, Langenberg C, Ben-Shlomo Y, Wannamethee SG, Strachan MW, Kumari M, Whittaker JC, Drenos F, Kivimaki M, Hingorani AD, Price JF, Humphries SE; UCLEB Consortium.

Diabetes. 2015 May;64(5):1830-40. doi: 10.2337/db14-1504. Epub 2014 Dec 4.

31.

Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the Edinburgh Type 2 Diabetes Study.

Bedenis R, Price AH, Robertson CM, Morling JR, Frier BM, Strachan MW, Price JF.

Diabetes Care. 2014 Dec;37(12):3301-8. doi: 10.2337/dc14-0908. Epub 2014 Sep 19.

PMID:
25239782
32.

N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

Price AH, Welsh P, Weir CJ, Feinkohl I, Robertson CM, Morling JR, McLachlan S, Strachan MW, Sattar N, Price JF.

Diabetologia. 2014 Dec;57(12):2505-12. doi: 10.1007/s00125-014-3375-9. Epub 2014 Sep 18.

PMID:
25231020
33.

Genome wide association identifies common variants at the SERPINA6/SERPINA1 locus influencing plasma cortisol and corticosteroid binding globulin.

Bolton JL, Hayward C, Direk N, Lewis JG, Hammond GL, Hill LA, Anderson A, Huffman J, Wilson JF, Campbell H, Rudan I, Wright A, Hastie N, Wild SH, Velders FP, Hofman A, Uitterlinden AG, Lahti J, Räikkönen K, Kajantie E, Widen E, Palotie A, Eriksson JG, Kaakinen M, Järvelin MR, Timpson NJ, Davey Smith G, Ring SM, Evans DM, St Pourcain B, Tanaka T, Milaneschi Y, Bandinelli S, Ferrucci L, van der Harst P, Rosmalen JG, Bakker SJ, Verweij N, Dullaart RP, Mahajan A, Lindgren CM, Morris A, Lind L, Ingelsson E, Anderson LN, Pennell CE, Lye SJ, Matthews SG, Eriksson J, Mellstrom D, Ohlsson C, Price JF, Strachan MW, Reynolds RM, Tiemeier H, Walker BR; CORtisol NETwork (CORNET) Consortium.

PLoS Genet. 2014 Jul 10;10(7):e1004474. doi: 10.1371/journal.pgen.1004474. eCollection 2014 Jul.

34.

Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3.

Hess K, Alzahrani SH, Price JF, Strachan MW, Oxley N, King R, Gamlen T, Schroeder V, Baxter PD, Ajjan RA.

Diabetologia. 2014 Aug;57(8):1737-41. doi: 10.1007/s00125-014-3267-z. Epub 2014 May 17.

PMID:
24838681
35.

Androgen deficiency and type 2 diabetes mellitus.

Gibb FW, Strachan MW.

Clin Biochem. 2014 Jul;47(10-11):940-9. doi: 10.1016/j.clinbiochem.2014.04.004. Epub 2014 Apr 24. Review.

PMID:
24768826
36.

Diabetes. Cognitive decline and T2DM--a disconnect in the evidence?

Strachan MW, Price JF.

Nat Rev Endocrinol. 2014 May;10(5):258-60. doi: 10.1038/nrendo.2014.38. Epub 2014 Apr 1.

PMID:
24686200
37.

Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetes.

Jenks SJ, Conway BR, Hor TJ, Williamson RM, McLachlan S, Robertson C, Morling JR, Strachan MW, Price JF.

Diabet Med. 2014 Sep;31(9):1039-46. doi: 10.1111/dme.12456. Epub 2014 Apr 16.

PMID:
24684407
38.

Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions.

Biessels GJ, Strachan MW, Visseren FL, Kappelle LJ, Whitmer RA.

Lancet Diabetes Endocrinol. 2014 Mar;2(3):246-55. doi: 10.1016/S2213-8587(13)70088-3. Epub 2013 Oct 18. Review.

PMID:
24622755
39.

Lessons learned from the introduction of an electronic safety net to enhance test result management in an Australian mothers' hospital.

Georgiou A, Lymer S, Forster M, Strachan M, Graham S, Hirst G, Callen J, Westbrook JI.

J Am Med Inform Assoc. 2014 Nov-Dec;21(6):1104-8. doi: 10.1136/amiajnl-2013-002466. Epub 2014 Mar 5.

40.

Scalable stacked array piezoelectric deformable mirror for astronomy and laser processing applications.

Wlodarczyk KL, Bryce E, Schwartz N, Strachan M, Hutson D, Maier RR, Atkinson D, Beard S, Baillie T, Parr-Burman P, Kirk K, Hand DP.

Rev Sci Instrum. 2014 Feb;85(2):024502. doi: 10.1063/1.4865125.

PMID:
24593375
41.

Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study.

Morling JR, Fallowfield JA, Guha IN, Nee LD, Glancy S, Williamson RM, Robertson CM, Strachan MW, Price JF; Edinburgh Type 2 Diabetes Study investigators.

J Hepatol. 2014 Feb;60(2):384-91. Epub 2013 Oct 26.

42.

Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study.

Morling JR, Fallowfield JA, Williamson RM, Nee LD, Jackson AP, Glancy S, Reynolds RM, Hayes PC, Guha IN, Strachan MW, Price JF.

Liver Int. 2014 Sep;34(8):1267-77. doi: 10.1111/liv.12385. Epub 2013 Dec 3.

43.

Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetes.

Anderssohn M, McLachlan S, Lüneburg N, Robertson C, Schwedhelm E, Williamson RM, Strachan MW, Ajjan R, Grant PJ, Böger RH, Price JF.

Diabetes Care. 2014;37(3):846-54. doi: 10.2337/dc13-0546. Epub 2013 Nov 1.

PMID:
24186881
44.

Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study.

Feinkohl I, Aung PP, Keller M, Robertson CM, Morling JR, McLachlan S, Deary IJ, Frier BM, Strachan MW, Price JF; Edinburgh Type 2 Diabetes Study (ET2DS) Investigators.

Diabetes Care. 2014 Feb;37(2):507-15. doi: 10.2337/dc13-1384. Epub 2013 Oct 8.

PMID:
24103900
45.

Association between excessive daytime sleepiness and severe hypoglycemia in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

Inkster B, Riha RL, Van Look L, Williamson R, McLachlan S, Frier BM, Strachan MW, Price JF, Reynolds RM.

Diabetes Care. 2013 Dec;36(12):4157-9. doi: 10.2337/dc13-0863. Epub 2013 Oct 2.

46.

Population genomics of cardiometabolic traits: design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) Consortium.

Shah T, Engmann J, Dale C, Shah S, White J, Giambartolomei C, McLachlan S, Zabaneh D, Cavadino A, Finan C, Wong A, Amuzu A, Ong K, Gaunt T, Holmes MV, Warren H, Swerdlow DI, Davies TL, Drenos F, Cooper J, Sofat R, Caulfield M, Ebrahim S, Lawlor DA, Talmud PJ, Humphries SE, Power C, Hypponen E, Richards M, Hardy R, Kuh D, Wareham N, Langenberg C, Ben-Shlomo Y, Day IN, Whincup P, Morris R, Strachan MW, Price J, Kumari M, Kivimaki M, Plagnol V, Dudbridge F, Whittaker JC, Casas JP, Hingorani AD; UCLEB Consortium.

PLoS One. 2013 Aug 20;8(8):e71345. doi: 10.1371/journal.pone.0071345. eCollection 2013. Erratum in: PLoS One. 2014;8(9): doi/10.1371/annotation/89b51e89-a415-49c7-9caa-8dfcf6fde855. Swerdlow, Daniel I [added]; Langenberg, Claudia [added].

47.
48.

Discordance in thyroglobulin measurements by radioimmunoassay and immunometric assay: a useful means of identifying thyroglobulin assay interference.

Crane MS, Strachan MW, Toft AD, Beckett GJ.

Ann Clin Biochem. 2013 Sep;50(Pt 5):421-32. doi: 10.1177/0004563213480492. Epub 2013 Jul 11.

PMID:
23847033
49.

Predictors of treatment failure, incipient hypothyroidism, and weight gain following radioiodine therapy for Graves' thyrotoxicosis.

Gibb FW, Zammitt NN, Beckett GJ, Strachan MW.

J Endocrinol Invest. 2013 Oct;36(9):764-9. doi: 10.3275/8949. Epub 2013 Apr 30.

PMID:
23633646
50.

Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

Feinkohl I, Keller M, Robertson CM, Morling JR, Williamson RM, Nee LD, McLachlan S, Sattar N, Welsh P, Reynolds RM, Russ TC, Deary IJ, Strachan MW, Price JF; Edinburgh Type 2 Diabetes Study (ET2DS) Investigators.

Diabetes Care. 2013 Sep;36(9):2779-86. doi: 10.2337/dc12-2241. Epub 2013 Apr 11.

Supplemental Content

Loading ...
Support Center